News

Dr. Desi Bartlett Teams Up with Glo for Perimenopause Focus

Dr. Desi Bartlett Teams Up with Glo for Perimenopause Focus

Glo Taps Top Wellness Expert for Women's Health Initiative

In an industry brimming with wellness voices, it's rare to find one that marries scholarly acumen with authentic, personal teaching. Yet, this is precisely what Dr. Desi Bartlett brings to the table as she partners with Glo to offer new fitness programming specifically targeting women facing perimenopause and midlife challenges. With 30 years of experience and a clutch of high-profile clients—think Kate Hudson, Emma Roberts—Dr. Bartlett isn't just another health guru; she's a heavyweight in women's health.

Her association with Glo—a big name in online yoga and mindful movement—comes just as Glo leaps into the expanding need for tailored wellness programs. Founded way back in 2008, Glo's been on a mission to democratize access to quality yoga and fitness classes. Their reach is far beyond the typical crowded studio, boasting thousands of video classes right at your fingertips. Now, they're putting a new spin on their offerings, honing in on life stages like perimenopause and menopause. And let's be real, this is no small market. We're talking about a natural phase in life that affects half the population.

A Fresh Focus on Perimenopause

Ah, perimenopause. A topic that's often hushed about in public circles but feels all too real behind closed doors. When Dr. Bartlett adds to Glo's repertoire, it’s not just a feather in her cap but potentially a lifeline for countless women navigating this stage. With her academic bona fides—a doctorate in Kinesiology focusing on yoga's impact on perimenopausal symptoms—in tow, she promises a program steeped in science, yet approachable.

"She has the academic credentials most wellness voices don't," says Kim Waters, Ph.D., Senior Content Manager at Glo.

Dr. Bartlett offers more than just a program; it’s an all-encompassing approach that marries mind and body. She's the mind behind The BodyMind Workout™, which probably gives you a good hint about her holistic approach.

Why Midlife Matters for Wellness

The timing couldn't be more perfect for Glo to shine a spotlight on midlife wellness. Just look at who Dr. Bartlett is aiming to support: women entering a phase often misunderstood and under-discussed. Perimenopause can be a particularly tricky terrain, with hormonal shifts that can knock even the sturdiest among us off balance, both physically and emotionally. That's why expert-led, science-backed programming isn't just nice to have; it's crucial.

And let's not forget the potential influence Dr. Bartlett wields. She's no stranger to the spotlight, with an impressive resume listing major networks like ABC and NBC. More eyes on her work means more eyes on this critical but often overlooked time in women's lives.

Glo and Beyond: Broadening the Reach

Glo's been in the game since 2008, founded by brothers Derik and Ryan Mills. From yoga to Pilates, they’ve covered the gamut of mindful exercise routines. But it's their mission to make these accessible to everyone that truly sets them apart. Dr. Bartlett's involvement only amplifies this mission, ensuring that programs are both inclusive and insightful.

Why should investors care? Well, companies like Glo that pivot effectively to focus on underserved niches have the potential to expand their user base significantly. Sure, it’s a wellness venture, not a high-stakes hedge fund; but filling the gap in women’s health is a move that's as morally savvy as it is fiscally smart. As they continue to fine-tune their offerings, keeping an eye on performance metrics like subscriber count, session engagement, and retention rates won’t just be insightful—it’ll be pivotal.

Final Thoughts

In an age where inclusivity and science-based wellness are finally gaining their deserved spotlight, Dr. Desi Bartlett's new partnership with Glo is both timely and potent. For women navigating midlife and the plethora of changes that come with it, this initiative is more than a fitness program—it’s a guiding light.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

First-Time Homeowners: Unseen Pitfalls of Insurance

Updated Category News Views 6

Understanding Homeowners Insurance: Beyond the Basics Most folks diving into homeownership for the first time get caught up in the whirlwind of price tags, loans, and knick-knacks for their new place. Meanwhile, the nitty-gritty of homeowners insurance often gets tossed to the side. But take it from a weary watchdog of financial storms—it’s those details in the policy...

Continue Reading
Tam-Peli Steps Up in SCLC Battle: Trial Insights

Updated Category News Views 5

Noteworthy Developments in Small-Cell Lung Cancer Treatment Let's dive into a story straight from the world of small-cell lung cancer (SCLC) that doesn't take any prisoners. The antidote making waves is tambotatug pelitecan, or Tam-Peli for short, showcasing its might in the unrelenting fight against relapsed SCLC. The phase III TAISHAN-302 trial puts Tam-Peli...

Continue Reading
UWM Faces Class Action Deadline: Key Insights for Investors

Updated Category News Views 3

The High Stakes Reality for UWM Investors If there's one thing that's certain in this jittery world of investing, it's that losses have a way of waking you up. Right now, anyone tied up with UWM Holdings Corporation (NYSE: UWMC) shares needs to keep their wits about them; we're barreling toward an October 13, 2026 deadline for a class action lawsuit. The clock's ticking...

Continue Reading
PANDAG G1 Debuts: Revolutionizing Lawn Care Efficiency

Updated Category News Views 6

The Future of Landscaping Unveiled Get this—PANDAG is set to shake things up at GaLaBau 2026 with their futuristic G1 autonomous mower. This isn't just another piece of lawn equipment; it's practically a tech marvel on wheels, weaving together LiDAR, AI Vision, RTK, and 4G tech to make it the ultimate multitasker for the landscaping industry. We're talking obstacle...

Continue Reading
MRI Surveillance Gains Ground in Lung Cancer Care

Updated Category News Views 7

Shifting the Standard: MRI's Rise in SCLC Treatment Here's a twist that baffles the traditionalists—ditch the prophylactic cranial irradiation (PCI) and catch clearer days with MRI surveillance for small-cell lung cancer (SCLC). The latest international phase III MAVERICK trial might just redraw the lines on what's considered standard care in this relentless disease....

Continue Reading
Trial Disappointment: No Significant Gains in NSCLC

Updated Category News Views 21

Dissecting the Nuances of the EVOKE-03/KEYNOTE-D46 Trial Every once in a while, we come across a trial that rattles cages in the research community. Today, it's the EVOKE-03/KEYNOTE-D46 trial, a collision of hope and hard-knock reality. This Phase 3 trial, which sought to explore the potential combo of sacituzumab govitecan (SG) and pembrolizumab on metastatic non-small...

Continue Reading
Ris-Rez May Set New Standard in Relapsed SCLC

Updated Category News Views 7

The Game-Changing Results Innovation in pharmaceuticals sometimes feels like a waiting game, but when a fresh breakthrough like this rolls in, it lights up the whole landscape. Risvutatug rezetecan, or Ris-Rez for short, has shown promising potential in the fight against relapsed small-cell lung cancer (SCLC) that has progressed after platinum-based therapy. Survival...

Continue Reading
Surfing Dogs Ride Waves, Support Orphan Pets

Updated Category News Views 3

Waves, Paws, and Passion Who would've thought that dogs catching waves could also catch hearts and wallets? Well, that's exactly what's happening today at Del Mar Dog Beach with the 21st Annual Surf Dog Surf-A-Thon revving up the excitement. It's a sun-soaked day in Rancho Santa Fe, California, right in the thick of things at the longest-running dog surf competition. For...

Continue Reading
GORGIE Unleashes Berry Burst: Target's New Drink Star

Updated Category News Views 6

GORGIE Targets Taste Buds with Berry Burst Ever feel like you're missing out on that energy drink everyone seems to be raving about? Well, GORGIE's out there making some noise again, and this time it's got a new punchy player in the game: Berry Burst. It's not just another drink; it's shaking things up in the energy aisle with its exclusive launch at Target. Modern style...

Continue Reading
Regeneron Faces Legal Heat: Lead Plaintiff Deadline Looms

Updated Category News Views 6

Regeneron’s Tight Spot: Legal Showdown Well, here we go again—Regeneron Pharmaceuticals (NASDAQ:REGN) is under some serious heat. If you're an investor who faced significant losses with this biotech juggernaut, remember that the clock’s ticking down to the wire. By tomorrow, September 14, 2026, you need to decide if you're going to throw your hat in the ring for...

Continue Reading

Top 5 Most Recently Viewed Articles

Hillwood Launches New Industrial Project on Kuser Road

Updated Category News Views 166

Hillwood's New Industrial Development Hillwood, a prominent player in the industrial real estate sector, has made a significant move with the groundbreaking of a new project on Kuser Road. This development spans 36 acres and is a part of Hillwood's strategy to enhance its portfolio in key logistics markets. The site, strategically located within a major logistics hub,...

Continue Reading
 Transforming $100 into Over $2,000: A Stock Journey

Updated Category News Views 197

The Growth of Insulet Corporation Over 15 Years Insulet Corporation (NASDAQ: PODD) has been a shining star in the stock market, consistently outperforming expectations and providing impressive returns to investors. Over the last 15 years, the company has exhibited an annualized return of 22.42%, surpassing the market by an impressive margin of 9.72%. Their current market...

Continue Reading
TRESU Investment Holding A/S Revises 2025 Financial Forecast

Updated Category News Views 203

TRESU Investment Holding A/S Adjusts Full Year 2025 Guidance TRESU Investment Holding A/S has recently announced a revision to its financial projections for the year 2025. This adjustment primarily stems from a noticeable slowdown in market demand, which has affected both the Systems and Machine & Units segments of the company, prompting a reevaluation of growth...

Continue Reading
Matson, Inc. Announces Participation in Major Logistics Event

Updated Category News Views 132

Matson to Attend Key Transportation and Logistics Conference Matson, Inc. (NYSE: MATX) is set to be a prominent participant at the upcoming Stifel Transportation & Logistics Conference. The event promises to be a significant gathering for industry leaders, with Matson's own CEO, Matt Cox, slated to attend. This participation exemplifies Matson's commitment to...

Continue Reading
Questerre Energy's Exciting Consolidation of Red Leaf Resources

Updated Category News Views 211

Questerre Energy's Bold Step Forward Questerre Energy Corporation (TSX: QEC) has announced a pivotal move to consolidate its interests in Red Leaf Resources, a strategic decision aimed at strengthening its position in the oil and gas market. By exchanging common shares from Red Leaf for its own Class "A" Common voting shares, Questerre aims to complete the acquisition of...

Continue Reading